Breast Cancer

Papers
(The H4-Index of Breast Cancer is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”166
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud64
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients42
Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society36
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy30
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can29
Low-carbohydrate diet score and risk of breast cancer: findings from a prospective cohort study25
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients23
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances22
Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study22
BARD1 and breast cancer genetic predisposition: case–control study and HRD signature analysis21
Factors associated with post acute care utilization after mastectomy for breast cancer patients21
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan20
The role of C1orf50 in breast cancer progression and prognosis20
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial19
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan19
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis19
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study19
Exploring a specialized lactylation pattern to predict the prognosis and sensitivity of immunotherapy in breast cancer via machine learning18
0.059626817703247